# Predicting SSRI Efficacy in Veterans With PTSD

> **NCT04183205** · PHASE4 · TERMINATED · sponsor: **VA Office of Research and Development** · enrollment: 26 (actual)

## Conditions studied

- Posttraumatic Stress Disorder
- Major Depressive Disorder

## Interventions

- **DIAGNOSTIC_TEST:** LDAEP
- **DRUG:** Placebo
- **DRUG:** sertraline

## Key facts

- **NCT ID:** NCT04183205
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-11
- **Primary completion:** 2025-03-30
- **Final completion:** 2025-03-31
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** difficulty meeting recruitment goals
- **Last updated:** 2026-02-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04183205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04183205, "Predicting SSRI Efficacy in Veterans With PTSD". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04183205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*